Bicara reaches substantial enrollment in HPV-negative head and neck cancer trialNov 9Quarterly updateArriVent BioPharma, Inc.Bicara Therapeutics
Coherus reports Q2 2026 results, flags October data update for tagmokitugAug 5Quarterly updateCoherus Oncology, Inc.toripalimab-tpzi